Corient Private Wealth
FLGT icon

Corient Private Wealth’s Fulgent Genetics FLGT Stock Holding History

Corient Private Wealth’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$931K Sell
45,394
-24,261
-35% -$411K ﹤0.01% 1862
2026
Q1 		$1.11M Buy
+69,655
New +$1.51M ﹤0.01% 1605

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Corient Private Wealth's FLGT Position: Q2 2026 in Review

Corient Private Wealth reduced its Fulgent Genetics (FLGT) stake by 35% in Q2 2026, selling an estimated $411K and leaving 45,394 shares worth $931K. The position accounts for ﹤0.01% of the portfolio, ranked #1862.

Corient Private Wealth first reported a position in FLGT in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.11M in Q1 2026. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Corient Private Wealth held 45,394 shares of Fulgent Genetics worth $931K as of Q2 2026.
  • Corient Private Wealth sold 24,261 Fulgent Genetics shares in Q2 2026, an estimated $411K.
  • Fulgent Genetics made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1862 holding.
  • Corient Private Wealth first reported a position in Fulgent Genetics in Q1 2026 and has held it in 2 quarters since.
  • Corient Private Wealth's Fulgent Genetics position peaked at $1.11M in Q1 2026.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.